Down-regulation of AGXT2L1 promotes the development of nonalcoholic fatty liver disease. [PDF]
Yu Y, Wu L.
europepmc +1 more source
Characterization of the gut virome in patients with nonalcoholic fatty liver disease. [PDF]
Wang L +10 more
europepmc +1 more source
Exploring the pathogenesis of nonalcoholic fatty liver disease complicated by atherosclerosis via bioinformatics. [PDF]
Yan R, Li P, Song J, Qiang Y, Zhai G.
europepmc +1 more source
The Therapeutic Effect and Mechanism of <i>Lactobacillus gardneri</i> on Nonalcoholic Fatty Liver Disease. [PDF]
Zhu K +6 more
europepmc +1 more source
Prevalence and dietary factors associated with nonalcoholic fatty liver disease in a sample of obese middle-aged Egyptian women. [PDF]
Moaty MIA +4 more
europepmc +1 more source
Study of Clinical Profile of Patients of Nonalcoholic Fatty Liver Disease and Its Correlation with Metabolic Syndrome. [PDF]
Shinde SG +6 more
europepmc +1 more source
Association Between Nonalcoholic Fatty Liver Disease and the Dietary Index for Gut Microbiota: A Cross-Sectional Study. [PDF]
Yang Q, Cai X, Li S, Xiao Z.
europepmc +1 more source
The emerging phenotype of nonalcoholic fatty liver disease in lean individuals: what's different? [PDF]
Dey P.
europepmc +1 more source
Network toxicology study and key target validation of chlorpyrifos-induced nonalcoholic fatty liver disease. [PDF]
Li Y +10 more
europepmc +1 more source
Impact of nonalcoholic fatty liver disease on atrial fibrillation recurrence after catheter ablation: a prospective cohort study. [PDF]
Xu Z +5 more
europepmc +1 more source

